In all, the 500 companies generated $13.8 trillion in revenue in 2020, according to the list released in June 2021.
Here are the top five drugmakers on the list, accompanied by their Fortune 500 ranking and full-year revenues in 2021:
Editor’s note: The revenues below are from 2021 and are not ordered from greatest to least, since Fortune’s list is based on 2020 revenues.
36. Johnson & Johnson: $93.8 billion
65. Merck: $48.7 billion
68. AbbVie: $56.1 billion
75. Bristol Myers Squibb: $46.4 billion
77. Pfizer: $81.3 billion
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.
